Oral Hypoglycemic Agents [PDF]
Primary Care: Clinics in Office Practice, 1977 Oral agents should not be used in the treatment of patients with asymptomatic maturity-onset diabetes. The indication for sulfonylureas is symptomatic maturity-onset diabetes or excessive hyperglycemia--fasting blood sugar over 300 mg per 100 ml--in the elderly patient who cannot or will not take insulin. The use of biguanides cannot be recommended.
Rifkin, Harold
core +9 more sources
Risk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: a large-scale medical receipt database analysis [PDF]
BMJ Open Diabetes Research & Care, 2023 Introduction Hypoglycemia is listed as an adverse effect in the package inserts of not only hypoglycemic agents but also many other drugs. We aimed to clarify real-world factors related to an increased risk of hypoglycemia-related hospitalization (HRH ...
Takeshi Horii, Mai Otsuka, Takeo Yasu
doaj +2 more sources
Re-starting or initiating guideline-recommended hypoglycemic agents for patients admitted with hyperglycemic crisis [PDF]
Frontiers in MedicineIntroductionHyperglycemic crises, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), are life-threatening complications of diabetes. This study aimed to assess the impact of early initiation of non-insulin hypoglycemic agents
Abdulrahman I. Alshaya +18 more
doaj +2 more sources
Hypoglycemic Agents and Anesthetic Techniques to Ameliorate Stress Hyperglycemia in Critically Ill Patients: A Systematic Review [PDF]
Journal of Research in Pharmacy Practice, 2023 The concurrent utilization of hypoglycemic agents and anesthetic techniques has been demonstrated to mitigate stress hyperglycemia in critically ill patients without diabetes, thereby contributing to enhanced patient outcomes.
Fatemeh Rahimpour +4 more
doaj +2 more sources
Hypoglycemic agents and potential anti-inflammatory activity [PDF]
Journal of Inflammation Research, 2016 Vishal Kothari,1 John A Galdo,2 Suresh T Mathews3 1Department of Nutrition and Dietetics, Boshell Diabetes and Metabolic Diseases Research Program, Auburn University, Auburn, 2Department of Pharmacy Practice, 3Department of Nutrition and Dietetics ...
Kothari V, Galdo JA, Mathews ST
doaj +2 more sources
Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis. [PDF]
Diab Vasc Dis Res, 2022 Oh S, Purja S, Shin H, Kim M, Kim E.
europepmc +3 more sources
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83). [PDF]
Diabetes Metab J, 2022 Oh TJ.
europepmc +4 more sources
New hypoglycemic agents and the kidney: what do the major trials tell us? [PDF]
F1000Res, 2018 Smyth B, Perkovic V.
europepmc +3 more sources
Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis. [PDF]
Medicine (Baltimore), 2020 Liu ST +4 more
europepmc +2 more sources
Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model [PDF]
International Journal of Scientific Research in Dental and Medical Sciences, 2022 Background and aim: The fruits of Cocos nucifera have long been used in traditional medicine as anti-inflammatory, antimicrobial, antiparasitic, anticancer, and cardiotonic.
Farjana Akter +5 more
doaj +1 more source